APA (7th ed.) Citation

Welt, A., Wiesweg, M., Theurer, S., Abenhardt, W., Groschek, M., Müller, L., . . . Breitenbücher, F. Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor‐positive, HER2‐negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression. Wiley.

Chicago Style (17th ed.) Citation

Welt, Anja, et al. Buparlisib in Combination with Tamoxifen in Pretreated Patients with Hormone Receptor‐positive, HER2‐negative Advanced Breast Cancer Molecularly Stratified for PIK3CA Mutations and Loss of PTEN Expression. Wiley.

MLA (9th ed.) Citation

Welt, Anja, et al. Buparlisib in Combination with Tamoxifen in Pretreated Patients with Hormone Receptor‐positive, HER2‐negative Advanced Breast Cancer Molecularly Stratified for PIK3CA Mutations and Loss of PTEN Expression. Wiley.